Cargando…
The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL
Decreased circulating levels of free thiols (R-SH, sulfhydryl groups) reflect enhanced oxidative stress, which plays an important role in the pathogenesis of cardiometabolic diseases. Since hyperglycemia causes oxidative stress, we questioned whether plasma free thiols are altered in patients with t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019670/ https://www.ncbi.nlm.nih.gov/pubmed/31878321 http://dx.doi.org/10.3390/jcm9010049 |
_version_ | 1783497573006311424 |
---|---|
author | van Dijk, Peter R. Abdulle, Amaal Eman Bulthuis, Marian L.C. Perton, Frank G. Connelly, Margery A. van Goor, Harry Dullaart, Robin P.F. |
author_facet | van Dijk, Peter R. Abdulle, Amaal Eman Bulthuis, Marian L.C. Perton, Frank G. Connelly, Margery A. van Goor, Harry Dullaart, Robin P.F. |
author_sort | van Dijk, Peter R. |
collection | PubMed |
description | Decreased circulating levels of free thiols (R-SH, sulfhydryl groups) reflect enhanced oxidative stress, which plays an important role in the pathogenesis of cardiometabolic diseases. Since hyperglycemia causes oxidative stress, we questioned whether plasma free thiols are altered in patients with type 2 diabetes mellitus (T2DM) without cardiovascular disease or renal function impairment. We also determined their relationship with elevated triglycerides and very low density lipoproteins (VLDL), a central feature of diabetic dyslipidemia. Fasting plasma free thiols (colorimetric method), lipoproteins, VLDL (nuclear magnetic resonance spectrometry), free fatty acids (FFA), phospholipid transfer protein (PLTP) activity and adiponectin were measured in 79 adult non-smoking T2DM subjects (HbA1c 51 ± 8 mmol/mol, no use of insulin or lipid lowering drugs), and in 89 non-smoking subjects without T2DM. Plasma free thiols were univariately correlated with glucose (r = 0.196, p < 0.05), but were not decreased in T2DM subjects versus non-diabetic subjects (p = 0.31). Free thiols were higher in subjects with (663 ± 84 µmol/L) versus subjects without elevated triglycerides (619 ± 91 µmol/L; p = 0.002). Age- and sex-adjusted multivariable linear regression analysis demonstrated that plasma triglycerides were positively and independently associated with free thiols (β = 0.215, p = 0.004), FFA (β = 0.168, p = 0.029) and PLTP activity (β = 0.228, p = 0.002), inversely with adiponectin (β = −0.308, p < 0.001) but not with glucose (β = 0.052, p = 0.51). Notably, the positive association of free thiols with (elevated) triglycerides appeared to be particularly evident in men. Additionally, large VLDL were independently associated with free thiols (β = 0.188, p = 0.029). In conclusion, circulating free thiols are not decreased in this cohort of non-smoking and generally well-controlled T2DM subjects. Paradoxically, higher triglycerides and more large VLDL particles are likely associated with higher plasma levels of thiols, reflecting lower systemic oxidative stress. |
format | Online Article Text |
id | pubmed-7019670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70196702020-03-09 The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL van Dijk, Peter R. Abdulle, Amaal Eman Bulthuis, Marian L.C. Perton, Frank G. Connelly, Margery A. van Goor, Harry Dullaart, Robin P.F. J Clin Med Article Decreased circulating levels of free thiols (R-SH, sulfhydryl groups) reflect enhanced oxidative stress, which plays an important role in the pathogenesis of cardiometabolic diseases. Since hyperglycemia causes oxidative stress, we questioned whether plasma free thiols are altered in patients with type 2 diabetes mellitus (T2DM) without cardiovascular disease or renal function impairment. We also determined their relationship with elevated triglycerides and very low density lipoproteins (VLDL), a central feature of diabetic dyslipidemia. Fasting plasma free thiols (colorimetric method), lipoproteins, VLDL (nuclear magnetic resonance spectrometry), free fatty acids (FFA), phospholipid transfer protein (PLTP) activity and adiponectin were measured in 79 adult non-smoking T2DM subjects (HbA1c 51 ± 8 mmol/mol, no use of insulin or lipid lowering drugs), and in 89 non-smoking subjects without T2DM. Plasma free thiols were univariately correlated with glucose (r = 0.196, p < 0.05), but were not decreased in T2DM subjects versus non-diabetic subjects (p = 0.31). Free thiols were higher in subjects with (663 ± 84 µmol/L) versus subjects without elevated triglycerides (619 ± 91 µmol/L; p = 0.002). Age- and sex-adjusted multivariable linear regression analysis demonstrated that plasma triglycerides were positively and independently associated with free thiols (β = 0.215, p = 0.004), FFA (β = 0.168, p = 0.029) and PLTP activity (β = 0.228, p = 0.002), inversely with adiponectin (β = −0.308, p < 0.001) but not with glucose (β = 0.052, p = 0.51). Notably, the positive association of free thiols with (elevated) triglycerides appeared to be particularly evident in men. Additionally, large VLDL were independently associated with free thiols (β = 0.188, p = 0.029). In conclusion, circulating free thiols are not decreased in this cohort of non-smoking and generally well-controlled T2DM subjects. Paradoxically, higher triglycerides and more large VLDL particles are likely associated with higher plasma levels of thiols, reflecting lower systemic oxidative stress. MDPI 2019-12-24 /pmc/articles/PMC7019670/ /pubmed/31878321 http://dx.doi.org/10.3390/jcm9010049 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article van Dijk, Peter R. Abdulle, Amaal Eman Bulthuis, Marian L.C. Perton, Frank G. Connelly, Margery A. van Goor, Harry Dullaart, Robin P.F. The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL |
title | The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL |
title_full | The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL |
title_fullStr | The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL |
title_full_unstemmed | The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL |
title_short | The Systemic Redox Status Is Maintained in Non-Smoking Type 2 Diabetic Subjects Without Cardiovascular Disease: Association with Elevated Triglycerides and Large VLDL |
title_sort | systemic redox status is maintained in non-smoking type 2 diabetic subjects without cardiovascular disease: association with elevated triglycerides and large vldl |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019670/ https://www.ncbi.nlm.nih.gov/pubmed/31878321 http://dx.doi.org/10.3390/jcm9010049 |
work_keys_str_mv | AT vandijkpeterr thesystemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT abdulleamaaleman thesystemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT bulthuismarianlc thesystemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT pertonfrankg thesystemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT connellymargerya thesystemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT vangoorharry thesystemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT dullaartrobinpf thesystemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT vandijkpeterr systemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT abdulleamaaleman systemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT bulthuismarianlc systemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT pertonfrankg systemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT connellymargerya systemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT vangoorharry systemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl AT dullaartrobinpf systemicredoxstatusismaintainedinnonsmokingtype2diabeticsubjectswithoutcardiovasculardiseaseassociationwithelevatedtriglyceridesandlargevldl |